103 related articles for article (PubMed ID: 10936244)
1. Recombinant Galalpha1,3Gal-substituted mucin/immunoglobulin chimeras: a superior absorber of anti-pig antibodies.
Liu J; Holgersson J
Transplant Proc; 2000 Aug; 32(5):859. PubMed ID: 10936244
[No Abstract] [Full Text] [Related]
2. Multivalent Galalpha1,3Gal-substitution makes recombinant mucin-immunoglobulins efficient absorbers of anti-pig antibodies.
Liu J; Weintraub A; Holgersson J
Xenotransplantation; 2003 Mar; 10(2):149-63. PubMed ID: 12588648
[TBL] [Abstract][Full Text] [Related]
3. Human natural antibodies cytotoxic to pig embryonic brain cells recognize novel non-Galalpha1,3Gal-based xenoantigens.
Sumitran S; Liu J; Czech KA; Christensson B; Widner H; Holgersson J
Exp Neurol; 1999 Oct; 159(2):347-61. PubMed ID: 10506507
[TBL] [Abstract][Full Text] [Related]
4. Studies on human naturally occurring antibodies to pig xenografts.
Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF
Transplant Proc; 1993 Oct; 25(5):2917-8. PubMed ID: 7692647
[No Abstract] [Full Text] [Related]
5. Xenotransplantation: in vitro analysis of synthetic alpha-galactosyl inhibitors of human anti-Galalpha1-->3Gal IgM and IgG antibodies.
Rieben R; Bovin NV; Korchagina EY; Oriol R; Nifant'ev NE; Tsvetkov DE; Daha MR; Mohacsi PJ; Joziasse DH
Glycobiology; 2000 Feb; 10(2):141-8. PubMed ID: 10642605
[TBL] [Abstract][Full Text] [Related]
6. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope.
Liu J; Qian Y; Holgersson J
Transplantation; 1997 Jun; 63(11):1673-82. PubMed ID: 9197365
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the human anti-pig natural antibody repertoire: implications for antigen-specific immunoadsorption.
McKane W; Lee J; Preston R; Hacking A; Simpson P; Lynds S; Goldberg L; Cairns T; Taube D
Transplantation; 1998 Sep; 66(5):626-33. PubMed ID: 9753344
[TBL] [Abstract][Full Text] [Related]
8. The sharing of target-epitopes between human anti-ABO hemagglutinating and anti-Pig (xeno) endothelium or anti-Pig thyroglobulin antibodies.
Morita N; Hagihara M; Kanai N; Hiraga S; Saito A; Sakai H; Tsuji K
Tokai J Exp Clin Med; 2003 Jul; 28(2):71-80. PubMed ID: 14714832
[TBL] [Abstract][Full Text] [Related]
9. Removal of anti-Gal alpha (1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells.
Azimzadeh A; Anegon I; Thibaudeau K; Charreau B; Zibolt P; Cinqualbre J; Soulillou JP; Wolf P
Transplant Proc; 1997 Aug; 29(5):2337. PubMed ID: 9270751
[No Abstract] [Full Text] [Related]
10. IgG2 anti-Galalpha1-3Gal does not induce porcine aortic endothelial cell accommodation in vitro.
McKane W; Lee J; Preston R; van Dam M; Cairns T; Taube D
Transplantation; 2000 Oct; 70(7):1085-93. PubMed ID: 11045647
[TBL] [Abstract][Full Text] [Related]
11. Absorption of anti-blood group A antibodies on P-selectin glycoprotein ligand-1/immunoglobulin chimeras carrying blood group A determinants: core saccharide chain specificity of the Se and H gene encoded alpha1,2 fucosyltransferases in different host cells.
Löfling JC; Hauzenberger E; Holgersson J
Glycobiology; 2002 Mar; 12(3):173-82. PubMed ID: 11971861
[TBL] [Abstract][Full Text] [Related]
12. Anti-pig antibody adsorption efficacy of {alpha}-Gal carrying recombinant P-selectin glycoprotein ligand-1/immunoglobulin chimeras increases with core 2 {beta}1, 6-N-acetylglucosaminyltransferase expression.
Liu J; Gustafsson A; Breimer ME; Kussak A; Holgersson J
Glycobiology; 2005 Jun; 15(6):571-83. PubMed ID: 15625182
[TBL] [Abstract][Full Text] [Related]
13. Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti-Galalpha1-3Gal antibodies from human serum.
Gerber B; Tinguely C; Bovin NV; Rieben R; Nydegger UE
Xenotransplantation; 2001 May; 8(2):106-14. PubMed ID: 11328581
[TBL] [Abstract][Full Text] [Related]
14. Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.
Mañez R; Domenech N; Centeno A; Lopez-Pelaez E; Crespo F; Juffe A; Duthaler RO; Katopodis AG
Xenotransplantation; 2004 Sep; 11(5):408-15. PubMed ID: 15303977
[TBL] [Abstract][Full Text] [Related]
15. The footprint of antibody bound to pig cells: evidence of complex surface topology.
Everett ML; Lin SS; Worrell SS; Platt JL; Parker W
Biochem Biophys Res Commun; 2003 Feb; 301(3):751-7. PubMed ID: 12565844
[TBL] [Abstract][Full Text] [Related]
16. The role of anti-Galalpha1-3Gal antibodies in acute vascular rejection and accommodation of xenografts.
Lin SS; Hanaway MJ; Gonzalez-Stawinski GV; Lau CL; Parker W; Davis RD; Byrne GW; Diamond LE; Logan JS; Platt JL
Transplantation; 2000 Dec; 70(12):1667-74. PubMed ID: 11152095
[TBL] [Abstract][Full Text] [Related]
17. Capture of anti-(Galalpha1-3Gal) antibodies by immobilized Galalpha1-3Gal oligomers derived from carrageenan.
Klein E; Euler M; Vercellotti J
Biotechnol Appl Biochem; 1998 Dec; 28 ( Pt 3)():189-99. PubMed ID: 9799716
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate.
Diamond LE; Byrne GW; Schwarz A; Davis TA; Adams DH; Logan JS
Transplantation; 2002 Jun; 73(11):1780-7. PubMed ID: 12085001
[TBL] [Abstract][Full Text] [Related]
19. Human anti-B alloantibodies recognize xenoantigens on pig red blood cells and endothelial cells.
Gautreau C; Woimant G; Grosse H; Cardoso J; Soubrane O; Houssin D
Transplant Proc; 1996 Apr; 28(2):563. PubMed ID: 8623273
[No Abstract] [Full Text] [Related]
20. Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands.
Parker W; Lateef J; Everett ML; Platt JL
Glycobiology; 1996 Jul; 6(5):499-506. PubMed ID: 8877370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
